Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

How to stent the ureter after kidney transplantation in children?-A comparison of two methods of urinary drainage.

Ter Haar AS, Parekh RS, Leunissen RWJ, van den J, Lorenzo AJ, Hebert D, Keijzer-Veen MG, Cransberg K.

Pediatr Transplant. 2018 Feb;22(1). doi: 10.1111/petr.13065. Epub 2017 Oct 27.

PMID:
29080255
2.

REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study- protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention study.

Schijvens AM, Dorresteijn EM, Roeleveld N, Ter Heine R, van Wijk JAE, Bouts AHM, Keijzer-Veen MG, van de Kar NCAJ, van den Heuvel LPWJ, Schreuder MF.

BMJ Open. 2017 Sep 27;7(9):e018148. doi: 10.1136/bmjopen-2017-018148.

3.

Serological and genetic complement alterations in infection-induced and complement-mediated hemolytic uremic syndrome.

Westra D, Volokhina EB, van der Molen RG, van der Velden TJ, Jeronimus-Klaasen A, Goertz J, Gracchi V, Dorresteijn EM, Bouts AH, Keijzer-Veen MG, van Wijk JA, Bakker JA, Roos A, van den Heuvel LP, van de Kar NC.

Pediatr Nephrol. 2017 Feb;32(2):297-309. doi: 10.1007/s00467-016-3496-0. Epub 2016 Oct 7.

4.

Screen-based identification and validation of four new ion channels as regulators of renal ciliogenesis.

Slaats GG, Wheway G, Foletto V, Szymanska K, van Balkom BW, Logister I, Den Ouden K, Keijzer-Veen MG, Lilien MR, Knoers NV, Johnson CA, Giles RH.

J Cell Sci. 2015 Dec 15;128(24):4550-9. doi: 10.1242/jcs.176065. Epub 2015 Nov 6.

5.

Non-invasive sources of cells with primary cilia from pediatric and adult patients.

Ajzenberg H, Slaats GG, Stokman MF, Arts HH, Logister I, Kroes HY, Renkema KY, van Haelst MM, Terhal PA, van Rooij IA, Keijzer-Veen MG, Knoers NV, Lilien MR, Jewett MA, Giles RH.

Cilia. 2015 Jun 1;4:8. doi: 10.1186/s13630-015-0017-x. eCollection 2015.

6.

Rituximab for patients with nephrotic syndrome.

Keijzer-Veen MG, Hebert D, Parekh RS; INSIGHT group.

Lancet. 2015 Jan 17;385(9964):225. doi: 10.1016/S0140-6736(15)60049-6. No abstract available.

PMID:
25706701
7.

Hemolytic uremic syndrome associated with Escherichia coli O8:H19 and Shiga toxin 2f gene.

Friesema IH, Keijzer-Veen MG, Koppejan M, Schipper HS, van Griethuysen AJ, Heck ME, van Pelt W.

Emerg Infect Dis. 2015 Jan;21(1):168-9. doi: 10.3201/eid2101.140515. No abstract available.

8.

Reduced renal length and volume 20 years after very preterm birth.

Keijzer-Veen MG, Devos AS, Meradji M, Dekker FW, Nauta J, van der Heijden BJ.

Pediatr Nephrol. 2010 Mar;25(3):499-507. doi: 10.1007/s00467-009-1371-y. Epub 2009 Dec 16.

9.

Very preterm birth is a risk factor for increased systolic blood pressure at a young adult age.

Keijzer-Veen MG, Dülger A, Dekker FW, Nauta J, van der Heijden BJ.

Pediatr Nephrol. 2010 Mar;25(3):509-16. doi: 10.1007/s00467-009-1373-9. Epub 2009 Dec 15.

10.

Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation.

Finken MJ, Keijzer-Veen MG, Dekker FW, Frölich M, Walther FJ, Romijn JA, van der Heijden BJ, Wit JM; Dutch POPS-19 Collaborative Study Group.

Arch Dis Child Fetal Neonatal Ed. 2008 Nov;93(6):F442-7. doi: 10.1136/adc.2007.128470. Epub 2008 May 1.

PMID:
18450806
11.

Renal function and size at young adult age after intrauterine growth restriction and very premature birth.

Keijzer-Veen MG, Kleinveld HA, Lequin MH, Dekker FW, Nauta J, de Rijke YB, van der Heijden BJ.

Am J Kidney Dis. 2007 Oct;50(4):542-51.

PMID:
17900453
12.

Lipid profile and carotid intima-media thickness in a prospective cohort of very preterm subjects at age 19 years: effects of early growth and current body composition.

Finken MJ, Inderson A, Van Montfoort N, Keijzer-Veen MG, van Weert AW, Carfil N, Frölich M, Hille ET, Romijn JA, Dekker FW, Wit JM; Dutch POPS-19 Collaborative Study Group.

Pediatr Res. 2006 Apr;59(4 Pt 1):604-9.

PMID:
16549538
13.

Preterm birth and later insulin resistance: effects of birth weight and postnatal growth in a population based longitudinal study from birth into adult life.

Finken MJ, Keijzer-Veen MG, Dekker FW, Frölich M, Hille ET, Romijn JA, Wit JM; Dutch POPS-19 Collaborative Study Group.

Diabetologia. 2006 Mar;49(3):478-85. Epub 2006 Feb 1.

PMID:
16450090
14.

A regression model with unexplained residuals was preferred in the analysis of the fetal origins of adult diseases hypothesis.

Keijzer-Veen MG, Euser AM, van Montfoort N, Dekker FW, Vandenbroucke JP, Van Houwelingen HC.

J Clin Epidemiol. 2005 Dec;58(12):1320-4. Epub 2005 Sep 12.

PMID:
16291478
15.

Is blood pressure increased 19 years after intrauterine growth restriction and preterm birth? A prospective follow-up study in The Netherlands.

Keijzer-Veen MG, Finken MJ, Nauta J, Dekker FW, Hille ET, Frölich M, Wit JM, van der Heijden AJ; Dutch POPS-19 Collaborative Study Group.

Pediatrics. 2005 Sep;116(3):725-31.

PMID:
16140714
16.

Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation.

Keijzer-Veen MG, Schrevel M, Finken MJ, Dekker FW, Nauta J, Hille ET, Frölich M, van der Heijden BJ; Dutch POPS-19 Collaborative Study Group.

J Am Soc Nephrol. 2005 Sep;16(9):2762-8. Epub 2005 Jun 29.

17.

Associations between prenatal and infancy weight gain and BMI, fat mass, and fat distribution in young adulthood: a prospective cohort study in males and females born very preterm.

Euser AM, Finken MJ, Keijzer-Veen MG, Hille ET, Wit JM, Dekker FW; Dutch POPS-19 Collaborative Study Group.

Am J Clin Nutr. 2005 Feb;81(2):480-7.

PMID:
15699238
18.

Reactogenicity of acellular pertussis vaccine in 4-year-olds in The Netherlands.

Keijzer-Veen MG, Holty-van der Wekken L, Juttmann RE, de Groot R, Rümke HC.

Vaccine. 2004 Sep 3;22(25-26):3256-7.

PMID:
15308347

Supplemental Content

Loading ...
Support Center